Business Context and Reporting Period
Company: The Clorox Company (CLX)
Filing Type: Form 8-K (Current Report)
Date of Report: May 19, 2025
Reporting Period: Event-based report regarding corporate governance amendments effective May 19, 2025.
Key Financial Metrics
This filing does not contain financial performance data. The document is a current report regarding corporate governance and does not provide values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The Board of Directors amended and restated the Company's Bylaws, effective May 19, 2025. The primary material change is the implementation of a cure process for deficiencies in director nomination notices submitted by shareholders. Under the new Bylaws, if a nomination notice is received within the specified timeframe but contains deficiencies, the Company will notify the shareholder, providing an opportunity to cure such deficiencies within a specified period.
Guidance, Outlook, and Risks
Management Commentary: The filing states that the description of the Bylaw amendments is not complete and is qualified in its entirety by reference to the full text of the Amended and Restated Bylaws filed as Exhibit 3.2.
Risks and Contingencies: No specific financial risks, contingencies, or unusual items are disclosed in this filing. The document focuses solely on the procedural update to shareholder nomination rules.
Investor Verification Checklist
- Review Exhibit 3.2 (Amended and Restated Bylaws) for the complete text of the new cure process.
- Verify the specific timeframes defined in the Bylaws for submitting nomination notices and curing deficiencies.
- Confirm that no other material events were reported in this specific 8-K filing.